News
FDA approves landmark pancreatic cancer drug that's shown to improve survival
Summary by The Los Angeles Editorial Desk Matthew Perrone and Lauran Neergaard | The Associated Press , as published by NBC Los Angeles (KNBC)
· August 26, 2026
· 1 min read
Photo: NBC Los Angeles (KNBC) · view original
Story provenance No corrections
Summary created by The Los Angeles Editorial Desk — automated, rule-governed Byline on source page Matthew Perrone and Lauran Neergaard | The Associated Press, as published by NBC Los Angeles (KNBC) Original story Read at the source Source published Aug 26, 2026 Indexed here Aug 27, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points The cost of a one-month supply has been announced by the company. A new treatment for pancreatic cancer has been approved by the FDA.
A new treatment for pancreatic cancer has been approved by the FDA. This approval brings a more effective option for patients. The daily medication, to be sold under a specific brand name, targets a protein that drives tumor growth.
Patients in a study saw significant improvement in survival time, with reduced severe side effects. The cost of a one-month supply has been announced by the company.
Further information on this development is available from the source, including details on the study and the medication's effects.
More News Today’s briefing Local events
Why this story is here
NBC Los Angeles (KNBC) reported and published this story. The Los Angeles selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by NBC Los Angeles (KNBC) . The Los Angeles selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit NBC Los Angeles (KNBC) . Have a tip or correction? Contact the editor .
Category: News Published: August 26, 2026 Source: NBC Los Angeles (KNBC) Reading time: 1 min
Frequently asked about this story
What is this story about? A new treatment for pancreatic cancer has been approved by the FDA. This approval brings a more effective option for patients. The daily medication, to be sold under a specific brand name, targets a…
When was this published? This article was first published on August 26, 2026 by NBC Los Angeles (KNBC) and curated for The Los Angeles readers.
Who reported this story? This story was reported by Matthew Perrone and Lauran Neergaard | The Associated Press at NBC Los Angeles (KNBC). To learn more about how The Los Angeles selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Los Angeles, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
